Skip to content

Clinical trials

Completed Phase 3 Leiomyoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyoma Phase: Phase 3 Status: Completed Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20033
20042
20062
20081
20103
20111
20122
20131
20143
20151
20164
20176
20181
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott6
AbbVie4
Myovant Sciences GmbH4
PregLem SA4
Allergan2
InSightec2
Kissei Pharmaceutical Co., Ltd.2
ObsEva SA2
Philips Healthcare2
Takeda2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyoma37
Menorrhagia17
Uterine Hemorrhage8
Metrorrhagia6
Myofibroma5
Neoplasms2
Connective Tissue Diseases1
Endometriosis1
Hemorrhage1
Neoplasms by Histologic Type1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.